Skip to main content
TipRanks
Go Ultimate75% OFF

ADARx Pharmaceuticals (ADRX) Income Statement

9 Followers

ADARx Pharmaceuticals Income Statement

Last quarter (Q3 2026), ADARx Pharmaceuticals's total revenue was $2.22M. In Q3, ADARx Pharmaceuticals's net income was $-28.12M. See ADARx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25
$ 3.45M
$ 3.45M
$ 91.81M
Depreciation and Amortization$ 2.33M
$ -86.04M
$ -88.36M
$ 15.28M
$ -73.09M
$ -73.09M
Per Share Metrics
Basic EPS$ -0.97
Diluted EPS$ -0.97
Weighted Average Shares Outstanding75.35M
Weighted Average Shares Outstanding (Diluted)75.35M

Currency in USD

ADARx Pharmaceuticals Earnings and Revenue History

-80M-40M040M-2121 %-2120 %-2119 %-2118 %EarningsProfit Margin2025RevenueEarningsProfit Margin